Top Stories

Monday, July 27, 2009

QLTI: 3.36 +0.35 (11.63%) - QLT Inc. (USA) ***** buy

QLTI: 3.36 +0.35 (11.63%) - QLT Inc. (USA): "# Range 3.01 - 3.51
# 52 week 1.40 - 4.09
# Open 3.07
# Vol / Avg. 1.61M/287,000.00
# Mkt cap 183.52M
# P/E 9.81
# Div -
# EPS 0.34
# Shares 54.62M
# Beta 1.33
# Inst"
TORONTO (DOW JONES)--QLT Inc.'s (QLTI) shares are up nearly 60% so far this month, a move the company's top executive says isn't surprising given how low the stock sank.

"I think we're moving towards a more reasonable valuation," said QLT Chief Executive Bob Butchofsky in an interview with Dow Jones. He added that QLT was recently trading below cash value, but has recovered along with other stocks in the ophthalmology sector.

On Nasdaq Monday, QLT is up 37 cents, or 12%, to $3.38 on 187,000 shares. The stock traded as low as $1.40 in March, and is at its highest level since September.
QLT Inc. (QLT), is a global biopharmaceutical company engaged in the business of discovering, developing and commercialization of therapies. QLT has two commercial products, Visudyne and Eligard. Visudyne utilizes photodynamic therapy (PDT), to treat the eye disease known as wet age related macular degeneration (wet AMD), the cause of blindness in people over the age of 55 in North America and Europe. Visudyne is also used for the treatment of subfoveal choroidal neovascularization (CNV) due to pathologic myopia, or severe near-sightedness, and presumed ocular histoplasmosis or other macular diseases. The Eligard product line includes one, three, four and six month commercial formulations of Atrigel technology combined with leuprolide acetate.

www.stockcaps.blogspot.com

No comments:

Wall Street Journal What's News

TheStreet Search RSS Feed: Cramer's Take: C

Money, Markets & More

Wall Street Journal This Morning

Wall Street Journal's Your Money Matters

Wall Street Journal Tech News Briefing

MarketWatch Internet Daily

MarketWatch Morning Stock Talk

Care2 News Network - Brain Food found by tapinder k.

WSJ.com Video - News/Analysis

Personal Journal

Weekend Journal

Weekend & Leisure

WSJ.com: Law

WSJ.com: Asia Markets News

WSJ.com: Health

WSJ.com: Media & Marketing

Wall Street Journal

News & Commentary

WSJ.com: Markets

WSJ.com: Europe Markets News

WSJ.com: Deals & Deal Makers

WSJ.com: Hedge Funds

Money and Investing

NEWSPAPER- Page One

Forums

Homes

Sports

Books

Careers

Health

Gadgets

Travel

Autos

Money

Tecnology

whats new

WSJ.com: Europe Technology

WSJ.com: Asia Technology

WSJ.com: E-Commerce/Media

WSJ.com: Telecommunications

WSJ.com: What's News Technology

WSJ.com: Gadgets

WSJ.com: Earnings

WSJ.com: What's News US

WSJ.com: What's News Asia

WSJ.com: Politics And Policy